Biotechnology
The Biotechnology industry has a total of 616 stocks, with a combined market cap of $999.52 billion and total revenue of $101.07 billion.
Market Cap
999.52B
Revenue
101.07B
Profits
-42.88B
PE Ratio
n/a
Profit Margin
-42.42%
Dividend Yield
0.04%
616 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 108.04B | -0.29% | 999,604 | 11.42B |
| 2 | ALNY | Alnylam Pharmaceuticals, Inc. | 60.75B | -0.12% | 771,271 | 2.46B |
| 3 | REGN | Regeneron Pharmaceuticals, Inc. | 59.93B | 0.39% | 875,427 | 14.21B |
| 4 | ARGX | argenx SE | 49.97B | 0.63% | 198,861 | 3.12B |
| 5 | ONC | BeOne Medicines AG | 34.22B | 0.25% | 112,626 | 4.56B |
| 6 | INSM | Insmed Incorporated | 33.75B | -0.29% | 1,111,095 | 398.11M |
| 7 | BNTX | BioNTech SE | 25.40B | 0.87% | 361,146 | 3.38B |
| 8 | RPRX | Royalty Pharma plc | 21.73B | 1.11% | 1,746,591 | 2.31B |
| 9 | GMAB | Genmab A/S | 18.32B | 0.07% | 3,904,637 | 3.65B |
| 10 | INCY | Incyte Corporation | 17.82B | 2.21% | 2,236,678 | 4.58B |
| 11 | SMMT | Summit Therapeutics Inc. | 14.35B | 2.83% | 3,772,480 | - |
| 12 | ROIV | Roivant Sciences Ltd. | 12.59B | 0.55% | 6,951,701 | 23.23M |
| 13 | ASND | Ascendis Pharma A/S | 12.34B | 0.49% | 369,022 | 576.33M |
| 14 | IONS | Ionis Pharmaceuticals, Inc. | 11.29B | -0.90% | 1,990,135 | 944.05M |
| 15 | BMRN | BioMarin Pharmaceutical Inc. | 10.46B | -0.13% | 2,101,028 | 3.06B |
| 16 | MRNA | Moderna, Inc. | 10.44B | 1.87% | 6,493,546 | 3.08B |
| 17 | EXEL | Exelixis, Inc. | 10.42B | 1.76% | 2,429,054 | 2.23B |
| 18 | BBIO | BridgeBio Pharma, Inc. | 10.37B | 0.84% | 1,497,375 | 235.81M |
| 19 | TECH | Bio-Techne Corporation | 10.26B | -0.23% | 1,806,567 | 1.22B |
| 20 | RVMD | Revolution Medicines, Inc. | 10.18B | 1.95% | 1,972,537 | - |
| 21 | MDGL | Madrigal Pharmaceuticals, Inc. | 9.39B | -0.56% | 163,445 | 515.55M |
| 22 | CAI | Caris Life Sciences, Inc. | 8.74B | -1.86% | 538,459 | 533.85M |
| 23 | JAZZ | Jazz Pharmaceuticals plc | 8.40B | 0.25% | 511,450 | 4.09B |
| 24 | HALO | Halozyme Therapeutics, Inc. | 7.74B | -1.11% | 994,183 | 1.18B |
| 25 | CORT | Corcept Therapeutics Incorporated | 7.64B | -0.63% | 456,328 | 716.08M |
| 26 | RYTM | Rhythm Pharmaceuticals, Inc. | 7.34B | 1.24% | 356,071 | 156.29M |
| 27 | MRUS | Merus N.V. | 7.19B | 0.49% | 2,500,742 | 56.23M |
| 28 | RNA | Avidity Biosciences, Inc. | 7.06B | 1.24% | 1,269,661 | 10.73M |
| 29 | ABVX | ABIVAX Société Anonyme | 6.96B | 0.32% | 795,696 | 7.07M |
| 30 | CYTK | Cytokinetics, Incorporated | 6.92B | 0.57% | 1,066,932 | 85.74M |
| 31 | NUVL | Nuvalent, Inc. | 6.73B | 2.75% | 853,798 | - |
| 32 | AXSM | Axsome Therapeutics, Inc. | 6.46B | 1.96% | 530,518 | 495.03M |
| 33 | CRSP | CRISPR Therapeutics AG | 6.15B | 0.60% | 1,341,717 | 38.05M |
| 34 | LEGN | Legend Biotech Corporation | 5.88B | 0.60% | 1,480,661 | 796.84M |
| 35 | MTSR | Metsera, Inc. | 5.53B | -0.23% | 507,273 | - |
| 36 | PCVX | Vaxcyte, Inc. | 5.48B | 1.54% | 1,057,398 | - |
| 37 | KRYS | Krystal Biotech, Inc. | 5.39B | -0.17% | 135,544 | 359.21M |
| 38 | PTCT | PTC Therapeutics, Inc. | 5.27B | -0.60% | 545,141 | 1.76B |
| 39 | ARWR | Arrowhead Pharmaceuticals, Inc. | 5.25B | 1.74% | 1,470,930 | 572.98M |
| 40 | TGTX | TG Therapeutics, Inc. | 4.86B | -0.46% | 1,171,183 | 454.07M |
| 41 | ACLX | Arcellx, Inc. | 4.70B | 0.73% | 238,089 | 56.98M |
| 42 | PTGX | Protagonist Therapeutics, Inc. | 4.66B | 1.18% | 690,656 | 209.18M |
| 43 | AKRO | Akero Therapeutics, Inc. | 4.31B | 0.09% | 638,003 | - |
| 44 | KYMR | Kymera Therapeutics, Inc. | 4.19B | 1.39% | 424,743 | 44.71M |
| 45 | NAMS | NewAmsterdam Pharma Company N.V. | 4.02B | -1.57% | 746,397 | 64.01M |
| 46 | VKTX | Viking Therapeutics, Inc. | 3.87B | 1.47% | 4,386,290 | - |
| 47 | CRNX | Crinetics Pharmaceuticals, Inc. | 3.86B | 2.27% | 761,336 | 1.39M |
| 48 | QURE | uniQure N.V. | 3.76B | 2.83% | 1,008,832 | 14.34M |
| 49 | ACAD | ACADIA Pharmaceuticals Inc. | 3.72B | 1.33% | 1,383,780 | 1.02B |
| 50 | PRAX | Praxis Precision Medicines, Inc. | 3.66B | -2.27% | 526,680 | 7.77M |
| 51 | TLX | Telix Pharmaceuticals Limited | 3.64B | -0.92% | 45,753 | 664.23M |
| 52 | ADMA | ADMA Biologics, Inc. | 3.62B | -0.46% | 5,567,385 | 474.17M |
| 53 | APLS | Apellis Pharmaceuticals, Inc. | 3.56B | -1.54% | 1,265,589 | 754.65M |
| 54 | MIRM | Mirum Pharmaceuticals, Inc. | 3.52B | 0.88% | 320,681 | 429.16M |
| 55 | APGE | Apogee Therapeutics, Inc. | 3.49B | -0.93% | 604,383 | - |
| 56 | SLNO | Soleno Therapeutics, Inc. | 3.41B | 0.82% | 603,111 | 32.66M |
| 57 | CGON | CG Oncology, Inc. | 3.33B | 4.03% | 662,141 | 551.00K |
| 58 | IMVT | Immunovant, Inc. | 3.30B | 1.07% | 833,519 | - |
| 59 | CNTA | Centessa Pharmaceuticals plc | 3.24B | 0.04% | 316,274 | 15.00M |
| 60 | RARE | Ultragenyx Pharmaceutical Inc. | 3.23B | -0.30% | 1,083,174 | 610.16M |
| 61 | AAPG | Ascentage Pharma Group International | 3.22B | 4.05% | 2,065 | 54.52M |
| 62 | XENE | Xenon Pharmaceuticals Inc. | 3.14B | -1.07% | 858,981 | 7.50M |
| 63 | MLYS | Mineralys Therapeutics, Inc. | 3.10B | -2.23% | 687,188 | - |
| 64 | BLTE | Belite Bio, Inc | 3.06B | 1.02% | 83,725 | - |
| 65 | CELC | Celcuity Inc. | 3.01B | 0.57% | 685,669 | - |
| 66 | IRON | Disc Medicine, Inc. | 2.98B | 2.32% | 322,477 | - |
| 67 | ZLAB | Zai Lab Limited | 2.93B | -6.07% | 1,004,936 | 427.80M |
| 68 | SRRK | Scholar Rock Holding Corporation | 2.85B | 3.56% | 1,920,799 | - |
| 69 | TARS | Tarsus Pharmaceuticals, Inc. | 2.79B | -3.31% | 727,013 | 295.52M |
| 70 | NTLA | Intellia Therapeutics, Inc. | 2.75B | -1.12% | 2,976,931 | 52.86M |
| 71 | BEAM | Beam Therapeutics Inc. | 2.75B | -0.85% | 1,549,121 | 60.27M |
| 72 | FOLD | Amicus Therapeutics, Inc. | 2.67B | 2.00% | 2,997,522 | 571.16M |
| 73 | RXRX | Recursion Pharmaceuticals, Inc. | 2.64B | 5.41% | 39,037,643 | 64.60M |
| 74 | ADPT | Adaptive Biotechnologies Corporation | 2.62B | 0.35% | 1,213,508 | 205.22M |
| 75 | CPRX | Catalyst Pharmaceuticals, Inc. | 2.57B | 1.11% | 890,879 | 558.50M |
| 76 | IDYA | IDEAYA Biosciences, Inc. | 2.56B | 2.67% | 864,153 | 7.00M |
| 77 | AGIO | Agios Pharmaceuticals, Inc. | 2.52B | 2.95% | 343,048 | 40.88M |
| 78 | TVTX | Travere Therapeutics, Inc. | 2.50B | -0.32% | 1,305,713 | 333.87M |
| 79 | DYN | Dyne Therapeutics, Inc. | 2.44B | 3.82% | 1,775,867 | - |
| 80 | OCUL | Ocular Therapeutix, Inc. | 2.43B | 0.44% | 1,634,466 | 56.66M |
| 81 | IBRX | ImmunityBio, Inc. | 2.43B | 3.35% | 10,620,307 | 56.60M |
| 82 | ARQT | Arcutis Biotherapeutics, Inc. | 2.41B | 0.15% | 1,186,118 | 263.47M |
| 83 | CDTX | Cidara Therapeutics, Inc. | 2.36B | -3.16% | 652,075 | 302.00K |
| 84 | DNLI | Denali Therapeutics Inc. | 2.34B | 0.50% | 1,073,826 | - |
| 85 | ETNB | 89bio, Inc. | 2.30B | -0.07% | 3,296,029 | - |
| 86 | SRPT | Sarepta Therapeutics, Inc. | 2.23B | 4.20% | 3,730,271 | 2.48B |
| 87 | MESO | Mesoblast Limited | 2.15B | -1.70% | 136,942 | 17.20M |
| 88 | GLPG | Galapagos NV | 2.13B | -0.03% | 134,287 | 323.67M |
| 89 | COGT | Cogent Biosciences, Inc. | 2.11B | 1.95% | 2,050,714 | - |
| 90 | LQDA | Liquidia Corporation | 1.93B | 1.63% | 1,008,013 | 19.32M |
| 91 | VERA | Vera Therapeutics, Inc. | 1.86B | 3.62% | 1,189,470 | - |
| 92 | RCUS | Arcus Biosciences, Inc. | 1.84B | 3.16% | 539,706 | 262.00M |
| 93 | VCEL | Vericel Corporation | 1.83B | 0.92% | 350,370 | 249.12M |
| 94 | SYRE | Spyre Therapeutics, Inc. | 1.81B | 4.47% | 700,507 | - |
| 95 | VRDN | Viridian Therapeutics, Inc. | 1.81B | 0.41% | 1,458,865 | 305.00K |
| 96 | CLDX | Celldex Therapeutics, Inc. | 1.77B | 1.75% | 461,405 | 5.79M |
| 97 | STOK | Stoke Therapeutics, Inc. | 1.77B | 1.86% | 641,014 | 199.89M |
| 98 | BHVN | Biohaven Ltd. | 1.76B | 1.84% | 1,281,509 | - |
| 99 | HRMY | Harmony Biosciences Holdings, Inc. | 1.74B | 2.20% | 933,454 | 772.53M |
| 100 | SION | Sionna Therapeutics, Inc. | 1.73B | -0.98% | 519,005 | - |
| 101 | ABCL | AbCellera Biologics Inc. | 1.69B | -0.88% | 4,736,214 | 32.88M |
| 102 | IMCR | Immunocore Holdings plc | 1.67B | 5.00% | 248,154 | 356.15M |
| 103 | PHVS | Pharvaris N.V. | 1.66B | -0.04% | 559,454 | - |
| 104 | NUVB | Nuvation Bio Inc. | 1.66B | 10.48% | 9,601,844 | 14.36M |
| 105 | MNKD | MannKind Corporation | 1.63B | -3.28% | 2,974,628 | 301.74M |
| 106 | EWTX | Edgewise Therapeutics, Inc. | 1.60B | 0.53% | 433,601 | - |
| 107 | AUPH | Aurinia Pharmaceuticals Inc. | 1.57B | 2.68% | 910,925 | 260.11M |
| 108 | GPCR | Structure Therapeutics Inc. | 1.52B | -0.64% | 770,302 | - |
| 109 | AMLX | Amylyx Pharmaceuticals, Inc. | 1.51B | -0.98% | 860,668 | -249.00K |
| 110 | JANX | Janux Therapeutics, Inc. | 1.50B | 1.80% | 501,779 | 439.00K |
| 111 | XERS | Xeris Biopharma Holdings, Inc. | 1.49B | 0.88% | 1,778,656 | 246.03M |
| 112 | SANA | Sana Biotechnology, Inc. | 1.46B | - | 3,632,900 | - |
| 113 | NVAX | Novavax, Inc. | 1.38B | 1.91% | 2,759,359 | 1.08B |
| 114 | IMNM | Immunome, Inc. | 1.37B | -2.30% | 1,166,625 | 12.59M |
| 115 | ZYME | Zymeworks Inc. | 1.33B | 1.90% | 816,056 | 122.87M |
| 116 | MAZE | Maze Therapeutics, Inc. | 1.33B | 1.64% | 286,991 | 2.50M |
| 117 | ORKA | Oruka Therapeutics, Inc. | 1.32B | 0.33% | 165,587 | - |
| 118 | TSHA | Taysha Gene Therapies, Inc. | 1.30B | -3.85% | 2,277,323 | 8.10M |
| 119 | PGEN | Precigen, Inc. | 1.29B | 1.88% | 3,742,340 | 4.34M |
| 120 | TRVI | Trevi Therapeutics, Inc. | 1.28B | -1.31% | 1,113,195 | - |
| 121 | DNTH | Dianthus Therapeutics, Inc. | 1.27B | -1.05% | 779,365 | 4.85M |
| 122 | ORIC | ORIC Pharmaceuticals, Inc. | 1.27B | 5.48% | 1,463,521 | - |
| 123 | TRML | Tourmaline Bio, Inc. | 1.24B | 0.04% | 628,776 | - |
| 124 | IMTX | Immatics N.V. | 1.24B | - | 277,183 | 152.82M |
| 125 | ATAI | Atai Life Sciences N.V. | 1.24B | 3.96% | 4,596,720 | 2.31M |
| 126 | ELVN | Enliven Therapeutics, Inc. | 1.22B | 0.29% | 371,209 | - |
| 127 | ARDX | Ardelyx, Inc. | 1.21B | -0.40% | 2,289,096 | 386.15M |
| 128 | YDES | YD Bio Limited | 1.21B | -2.39% | 44,361 | 510.36K |
| 129 | CVAC | CureVac N.V. | 1.21B | -0.37% | 191,131 | 599.54M |
| 130 | RAPP | Rapport Therapeutics, Inc. | 1.20B | -0.99% | 349,590 | - |
| 131 | RLAY | Relay Therapeutics, Inc. | 1.18B | 1.48% | 3,276,839 | 8.36M |
| 132 | UPB | Upstream Bio, Inc. | 1.18B | 3.41% | 185,990 | 2.72M |
| 133 | SNDX | Syndax Pharmaceuticals, Inc. | 1.17B | -7.83% | 14,951,258 | 77.93M |
| 134 | NKTR | Nektar Therapeutics | 1.14B | -5.56% | 1,356,188 | 74.93M |
| 135 | WVE | Wave Life Sciences Ltd. | 1.14B | 1.13% | 2,166,935 | 93.95M |
| 136 | INVA | Innoviva, Inc. | 1.12B | -3.01% | 530,699 | 370.23M |
| 137 | OCS | Oculis Holding AG | 1.11B | 0.23% | 107,837 | 960.67K |
| 138 | FTRE | Fortrea Holdings Inc. | 1.03B | 4.63% | 1,132,052 | 2.73B |
| 139 | ZBIO | Zenas BioPharma, Inc. | 1.01B | -4.46% | 630,066 | 15.00M |
| 140 | MDXG | MiMedx Group, Inc. | 1.00B | 1.81% | 529,455 | 363.77M |
| 141 | KOD | Kodiak Sciences Inc. | 985.03M | 9.23% | 1,160,245 | - |
| 142 | ANAB | AnaptysBio, Inc. | 981.85M | 3.15% | 198,349 | 123.16M |
| 143 | SEPN | Septerna, Inc. | 966.16M | -0.55% | 144,720 | 726.00K |
| 144 | PHAT | Phathom Pharmaceuticals, Inc. | 942.34M | -0.59% | 505,338 | 114.04M |
| 145 | MNMD | Mind Medicine (MindMed) Inc. | 941.97M | -0.72% | 826,698 | - |
| 146 | XNCR | Xencor, Inc. | 941.82M | 7.01% | 1,562,997 | 146.93M |
| 147 | PROK | ProKidney Corp. | 941.70M | 0.31% | 649,414 | 527.00K |
| 148 | BCAX | Bicara Therapeutics Inc. | 936.06M | 1.30% | 651,996 | - |
| 149 | PHAR | Pharming Group N.V. | 930.85M | -8.17% | 12,336 | 339.84M |
| 150 | SVRA | Savara Inc. | 918.61M | 5.83% | 1,611,599 | - |
| 151 | NBTX | Nanobiotix S.A. | 904.06M | -0.41% | 176,913 | 11.93M |
| 152 | PRME | Prime Medicine, Inc. | 900.90M | -0.93% | 1,818,204 | 4.96M |
| 153 | SPRY | ARS Pharmaceuticals, Inc. | 900.31M | -5.60% | 1,923,921 | 112.34M |
| 154 | URGN | UroGen Pharma Ltd. | 877.63M | 9.46% | 988,473 | 94.24M |
| 155 | CRMD | CorMedix Inc. | 871.92M | -1.24% | 1,841,754 | 121.48M |
| 156 | MRVI | Maravai LifeSciences Holdings, Inc. | 870.78M | -2.01% | 985,959 | 219.83M |
| 157 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 868.00M | 0.83% | 107,273 | - |
| 158 | GHRS | GH Research PLC | 865.31M | 5.12% | 185,896 | - |
| 159 | LENZ | LENZ Therapeutics, Inc. | 855.95M | 1.88% | 1,104,698 | 5.00M |
| 160 | NRIX | Nurix Therapeutics, Inc. | 852.64M | 6.63% | 2,465,345 | 83.69M |
| 161 | KURA | Kura Oncology, Inc. | 841.93M | 6.59% | 2,869,490 | 83.28M |
| 162 | ABUS | Arbutus Biopharma Corporation | 835.81M | 1.87% | 786,451 | 15.42M |
| 163 | RZLT | Rezolute, Inc. | 834.71M | 1.88% | 868,426 | - |
| 164 | TNGX | Tango Therapeutics, Inc. | 833.90M | -0.46% | 6,310,241 | 24.30M |
| 165 | VIR | Vir Biotechnology, Inc. | 830.72M | 3.46% | 1,415,169 | 19.00M |
| 166 | INBX | Inhibrx Biosciences, Inc. | 829.87M | 102.01% | 6,079,575 | 1.40M |
| 167 | EYPT | EyePoint Pharmaceuticals, Inc. | 825.75M | 4.17% | 1,121,669 | 51.90M |
| 168 | IOVA | Iovance Biotherapeutics, Inc. | 814.17M | 2.74% | 9,293,649 | 241.53M |
| 169 | VALN | Valneva SE | 811.81M | -1.86% | 42,808 | 230.57M |
| 170 | PVLA | Palvella Therapeutics, Inc. | 807.36M | 2.45% | 125,618 | - |
| 171 | GERN | Geron Corporation | 791.14M | 1.64% | 11,634,899 | 164.45M |
| 172 | DAWN | Day One Biopharmaceuticals, Inc. | 767.22M | 1.77% | 729,290 | 187.64M |
| 173 | MBX | MBX Biosciences, Inc. | 760.16M | 5.39% | 659,129 | - |
| 174 | TYRA | Tyra Biosciences, Inc. | 758.42M | 0.78% | 132,410 | - |
| 175 | AVBP | ArriVent BioPharma, Inc. | 754.18M | 2.76% | 292,538 | - |
| 176 | DNA | Ginkgo Bioworks Holdings, Inc. | 752.12M | 2.73% | 1,170,299 | 230.82M |
| 177 | GYRE | Gyre Therapeutics, Inc. | 742.05M | -0.73% | 43,910 | 102.19M |
| 178 | AVXL | Anavex Life Sciences Corp. | 739.98M | -1.43% | 804,619 | - |
| 179 | TBPH | Theravance Biopharma, Inc. | 719.16M | 0.78% | 220,285 | 77.21M |
| 180 | ATXS | Astria Therapeutics, Inc. | 702.05M | 0.48% | 812,150 | - |
| 181 | MGTX | MeiraGTx Holdings plc | 701.50M | -0.34% | 406,645 | 37.92M |
| 182 | GLUE | Monte Rosa Therapeutics, Inc. | 688.00M | 7.32% | 1,044,171 | 177.99M |
| 183 | REPL | Replimune Group, Inc. | 686.89M | 4.51% | 2,184,295 | - |
| 184 | CMPX | Compass Therapeutics, Inc. | 681.14M | 2.06% | 843,127 | 850.00K |
| 185 | TERN | Terns Pharmaceuticals, Inc. | 679.96M | 3.60% | 1,739,428 | - |
| 186 | ARVN | Arvinas, Inc. | 676.18M | 0.55% | 3,459,405 | 372.80M |
| 187 | ERAS | Erasca, Inc. | 675.13M | 7.69% | 1,179,750 | - |
| 188 | RGNX | REGENXBIO Inc. | 658.20M | 3.58% | 461,729 | 155.78M |
| 189 | ABSI | Absci Corporation | 638.46M | -0.12% | 3,640,612 | 4.14M |
| 190 | KROS | Keros Therapeutics, Inc. | 610.86M | 1.08% | 700,809 | 232.84M |
| 191 | NAGE | Niagen Bioscience, Inc. | 604.99M | 2.02% | 667,006 | 116.30M |
| 192 | MLTX | MoonLake Immunotherapeutics | 604.53M | 0.63% | 1,660,301 | - |
| 193 | ZVRA | Zevra Therapeutics, Inc. | 595.59M | -0.66% | 707,593 | 62.02M |
| 194 | MNPR | Monopar Therapeutics Inc. | 587.66M | 0.34% | 51,787 | - |
| 195 | GOSS | Gossamer Bio, Inc. | 570.10M | 18.66% | 7,741,779 | 40.24M |
| 196 | KALV | KalVista Pharmaceuticals, Inc. | 562.32M | 1.18% | 1,223,595 | 1.43M |
| 197 | OLMA | Olema Pharmaceuticals, Inc. | 551.13M | -0.74% | 1,137,004 | - |
| 198 | CRVS | Corvus Pharmaceuticals, Inc. | 547.68M | 2.65% | 1,125,410 | - |
| 199 | BCYC | Bicycle Therapeutics plc | 546.14M | 0.90% | 268,297 | 19.28M |
| 200 | CTMX | CytomX Therapeutics, Inc. | 537.62M | -1.21% | 1,738,638 | 141.10M |
| 201 | RIGL | Rigel Pharmaceuticals, Inc. | 537.58M | 1.97% | 297,481 | 267.92M |
| 202 | FDMT | 4D Molecular Therapeutics, Inc. | 529.61M | 13.40% | 2,318,082 | 33.00K |
| 203 | PRTA | Prothena Corporation plc | 528.61M | 0.72% | 362,600 | 10.34M |
| 204 | LXRX | Lexicon Pharmaceuticals, Inc. | 516.03M | 1.43% | 1,009,961 | 58.43M |
| 205 | OMER | Omeros Corporation | 513.82M | -1.31% | 1,341,108 | - |
| 206 | OCGN | Ocugen, Inc. | 502.81M | 5.23% | 3,633,884 | 4.75M |
| 207 | FULC | Fulcrum Therapeutics, Inc. | 498.72M | 2.79% | 406,204 | 80.00M |
| 208 | LXEO | Lexeo Therapeutics, Inc. | 498.40M | 2.56% | 639,674 | - |
| 209 | IVA | Inventiva S.A. | 492.06M | 5.62% | 168,943 | 19.93M |
| 210 | VSTM | Verastem, Inc. | 489.28M | 1.79% | 1,628,566 | 2.14M |
| 211 | RAPT | RAPT Therapeutics, Inc. | 488.36M | -1.57% | 555,135 | - |
| 212 | IMAB | I-Mab | 486.42M | -3.87% | 1,358,936 | 569.46K |
| 213 | IVVD | Invivyd, Inc. | 478.13M | 14.95% | 6,787,929 | 46.21M |
| 214 | ALMS | Alumis Inc. | 469.33M | -2.17% | 352,847 | 20.06M |
| 215 | OPT | Opthea Limited | 466.57M | - | - | 146.00K |
| 216 | ADCT | ADC Therapeutics SA | 460.12M | 0.49% | 492,023 | 77.25M |
| 217 | CGEM | Cullinan Therapeutics, Inc. | 458.42M | 0.39% | 979,689 | - |
| 218 | ASMB | Assembly Biosciences, Inc. | 454.66M | 6.25% | 73,695 | 33.25M |
| 219 | SLDB | Solid Biosciences Inc. | 437.62M | 1.81% | 734,805 | - |
| 220 | DRUG | Bright Minds Biosciences Inc. | 437.20M | -0.58% | 302,385 | - |
| 221 | BNTC | Benitec Biopharma Inc. | 433.66M | 4.49% | 72,517 | - |
| 222 | PRTC | PureTech Health plc | 429.59M | 4.83% | 3,863 | 6.39M |
| 223 | NGNE | Neurogene Inc. | 426.59M | 4.11% | 107,551 | 925.00K |
| 224 | NMRA | Neumora Therapeutics, Inc. | 425.92M | 13.85% | 5,458,132 | - |
| 225 | XOMA | XOMA Royalty Corporation | 425.13M | 2.63% | 31,300 | 44.95M |
| 226 | DBVT | DBV Technologies S.A. | 423.96M | 3.70% | 108,264 | 3.80M |
| 227 | ENGN | enGene Holdings Inc. | 419.77M | 4.19% | 104,379 | - |
| 228 | RCKT | Rocket Pharmaceuticals, Inc. | 415.43M | 2.94% | 1,239,841 | - |
| 229 | VTYX | Ventyx Biosciences, Inc. | 414.30M | -11.97% | 12,475,428 | - |
| 230 | AUTL | Autolus Therapeutics plc | 407.20M | 2.00% | 1,276,475 | 29.93M |
| 231 | LCTX | Lineage Cell Therapeutics, Inc. | 388.21M | 4.29% | 1,005,038 | 10.91M |
| 232 | IMRX | Immuneering Corporation | 381.96M | 7.28% | 1,080,001 | - |
| 233 | AURA | Aura Biosciences, Inc. | 364.02M | 3.17% | 337,230 | - |
| 234 | LRMR | Larimar Therapeutics, Inc. | 360.34M | 6.58% | 1,548,855 | - |
| 235 | DRTS | Alpha Tau Medical Ltd. | 359.73M | 0.48% | 28,600 | - |
| 236 | LBRX | LB Pharmaceuticals Inc | 358.41M | 0.82% | 107,675 | - |
| 237 | KRRO | Korro Bio, Inc. | 357.70M | 1.57% | 251,707 | 6.28M |
| 238 | DMAC | DiaMedica Therapeutics Inc. | 355.62M | 1.78% | 309,492 | - |
| 239 | ANNX | Annexon, Inc. | 352.74M | 5.25% | 3,192,061 | - |
| 240 | ALT | Altimmune, Inc. | 348.62M | -0.25% | 1,931,656 | 20.00K |
| 241 | SLN | Silence Therapeutics plc | 344.81M | 0.69% | 385,383 | 27.17M |
| 242 | LYEL | Lyell Immunopharma, Inc. | 338.89M | -3.71% | 19,625 | 60.00K |
| 243 | GALT | Galectin Therapeutics Inc. | 335.04M | 1.95% | 194,999 | - |
| 244 | EDIT | Editas Medicine, Inc. | 334.50M | 1.92% | 1,625,533 | 38.90M |
| 245 | DSGN | Design Therapeutics, Inc. | 326.31M | 0.53% | 86,493 | - |
| 246 | JBIO | Jade Biosciences, Inc. | 326.27M | 0.70% | 94,316 | - |
| 247 | VNDA | Vanda Pharmaceuticals Inc. | 324.99M | 0.18% | 518,783 | 203.47M |
| 248 | KYTX | Kyverna Therapeutics, Inc. | 321.75M | 16.25% | 897,668 | - |
| 249 | ACIU | AC Immune SA | 321.57M | 15.66% | 589,347 | 36.36M |
| 250 | TECX | Tectonic Therapeutic, Inc. | 320.91M | -1.38% | 277,268 | - |
| 251 | HUMA | Humacyte, Inc. | 320.23M | 1.18% | 2,691,752 | 818.00K |
| 252 | MREO | Mereo BioPharma Group plc | 318.19M | - | 1,523,240 | 500.00K |
| 253 | ALDX | Aldeyra Therapeutics, Inc. | 314.64M | 1.16% | 309,178 | - |
| 254 | PEPG | PepGen Inc. | 314.13M | 1.56% | 509,516 | - |
| 255 | CTNM | Contineum Therapeutics, Inc. | 309.86M | -0.63% | 50,838 | - |
| 256 | PRQR | ProQR Therapeutics N.V. | 309.71M | 4.26% | 394,106 | 20.13M |
| 257 | ARCT | Arcturus Therapeutics Holdings Inc. | 304.67M | -6.50% | 3,862,047 | 122.12M |
| 258 | ANRO | Alto Neuroscience, Inc. | 297.84M | -1.61% | 356,503 | - |
| 259 | SGMT | Sagimet Biosciences Inc. | 297.25M | 24.69% | 2,534,617 | - |
| 260 | CADL | Candel Therapeutics, Inc. | 296.43M | 1.69% | 574,139 | - |
| 261 | TENX | Tenax Therapeutics, Inc. | 295.53M | 0.82% | 27,685 | - |
| 262 | ENTA | Enanta Pharmaceuticals, Inc. | 293.00M | -1.59% | 356,972 | 64.81M |
| 263 | IMMP | Immutep Limited | 292.16M | 1.49% | 61,417 | 3.31M |
| 264 | GNLX | Genelux Corporation | 292.00M | 1.43% | 327,276 | 8.00K |
| 265 | ETHZ | ETHZilla Corporation | 288.80M | 17.38% | 3,159,205 | - |
| 266 | CAPR | Capricor Therapeutics, Inc. | 283.45M | 1.14% | 1,113,189 | 13.39M |
| 267 | ABEO | Abeona Therapeutics Inc. | 281.01M | 1.11% | 821,234 | 400.00K |
| 268 | EPRX | Eupraxia Pharmaceuticals Inc. | 276.19M | -3.70% | 55,455 | - |
| 269 | TNYA | Tenaya Therapeutics, Inc. | 270.54M | -1.19% | 2,444,151 | - |
| 270 | ALLO | Allogene Therapeutics, Inc. | 266.26M | -0.83% | 1,739,604 | 22.00K |
| 271 | PBYI | Puma Biotechnology, Inc. | 263.44M | 3.77% | 365,656 | 238.06M |
| 272 | VYGR | Voyager Therapeutics, Inc. | 257.93M | 2.20% | 421,596 | 42.58M |
| 273 | ACHV | Achieve Life Sciences, Inc. | 255.52M | 1.63% | 1,206,244 | - |
| 274 | AVIR | Atea Pharmaceuticals, Inc. | 254.34M | 0.47% | 236,098 | - |
| 275 | CLLS | Cellectis S.A. | 251.54M | 0.29% | 44,046 | 63.44M |
| 276 | FENC | Fennec Pharmaceuticals Inc. | 250.21M | 0.33% | 30,903 | 33.30M |
| 277 | SLS | SELLAS Life Sciences Group, Inc. | 248.91M | 4.19% | 3,426,270 | - |
| 278 | CBIO | Crescent Biopharma, Inc. | 248.09M | -0.78% | 56,960 | - |
| 279 | CDXS | Codexis, Inc. | 243.27M | 4.05% | 425,746 | 57.16M |
| 280 | TRDA | Entrada Therapeutics, Inc. | 242.83M | 6.72% | 222,354 | 79.48M |
| 281 | ZURA | Zura Bio Limited | 239.92M | 9.82% | 637,522 | - |
| 282 | RNAC | Cartesian Therapeutics, Inc. | 238.18M | 1.78% | 68,514 | 1.03M |
| 283 | MDWD | MediWound Ltd. | 236.43M | -0.32% | 20,347 | 19.86M |
| 284 | OABI | OmniAb, Inc. | 234.65M | 1.87% | 267,288 | 23.03M |
| 285 | ACRS | Aclaris Therapeutics, Inc. | 232.91M | -4.87% | 1,911,928 | 16.79M |
| 286 | AARD | Aardvark Therapeutics, Inc. | 232.16M | -1.38% | 121,770 | - |
| 287 | CRBU | Caribou Biosciences, Inc. | 231.88M | -0.40% | 656,701 | 9.12M |
| 288 | AVTX | Avalo Therapeutics, Inc. | 231.09M | -1.95% | 515,589 | 441.00K |
| 289 | TLSA | Tiziana Life Sciences Ltd | 230.52M | 2.11% | 88,826 | - |
| 290 | FHTX | Foghorn Therapeutics Inc. | 230.08M | 4.36% | 234,076 | 24.17M |
| 291 | CCCC | C4 Therapeutics, Inc. | 228.01M | 2.94% | 1,814,457 | 34.24M |
| 292 | CABA | Cabaletta Bio, Inc. | 225.92M | 2.49% | 1,846,184 | - |
| 293 | BDTX | Black Diamond Therapeutics, Inc. | 223.76M | 1.29% | 487,025 | 70.00M |
| 294 | HRTX | Heron Therapeutics, Inc. | 219.98M | 0.84% | 2,788,760 | 149.69M |
| 295 | ARMP | Armata Pharmaceuticals, Inc. | 219.55M | -14.65% | 235,694 | 6.87M |
| 296 | FBRX | Forte Biosciences, Inc. | 216.31M | 0.66% | 241,522 | - |
| 297 | GNFT | Genfit S.A. | 216.05M | -0.35% | 1,609 | 52.99M |
| 298 | PYXS | Pyxis Oncology, Inc. | 214.58M | 2.37% | 315,743 | 2.82M |
| 299 | OBIO | Orchestra BioMed Holdings, Inc. | 213.66M | 4.21% | 297,098 | 2.94M |
| 300 | ELDN | Eledon Pharmaceuticals, Inc. | 208.39M | 5.78% | 1,576,604 | - |
| 301 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 206.87M | -2.88% | 188,328 | - |
| 302 | IPHA | Innate Pharma S.A. | 198.34M | 0.46% | 9,474 | 14.84M |
| 303 | APLT | Applied Therapeutics, Inc. | 197.30M | - | 1,650,100 | 121.00K |
| 304 | TARA | Protara Therapeutics, Inc. | 196.77M | -1.16% | 409,192 | - |
| 305 | CHRS | Coherus Oncology, Inc. | 191.78M | -1.20% | 549,709 | 272.21M |
| 306 | SGMO | Sangamo Therapeutics, Inc. | 191.07M | -3.58% | 4,321,854 | 81.71M |
| 307 | FATE | Fate Therapeutics, Inc. | 190.29M | 8.55% | 3,711,080 | 8.47M |
| 308 | PLX | Protalix BioTherapeutics, Inc. | 188.17M | 2.16% | 740,682 | 61.95M |
| 309 | VOR | Vor Biopharma Inc. | 186.36M | -2.05% | 276,933 | - |
| 310 | MIST | Milestone Pharmaceuticals Inc. | 184.06M | -0.53% | 1,455,763 | - |
| 311 | SAVA | Cassava Sciences, Inc. | 182.60M | -3.32% | 1,728,887 | - |
| 312 | GUTS | Fractyl Health, Inc. | 182.43M | - | 908,839 | 17.00K |
| 313 | NKTX | Nkarta, Inc. | 171.17M | 6.64% | 1,064,928 | - |
| 314 | CAMP | Camp4 Therapeutics Corporation | 170.97M | 4.89% | 66,240 | 3.01M |
| 315 | TNXP | Tonix Pharmaceuticals Holding Corp. | 170.85M | 4.90% | 462,320 | 9.83M |
| 316 | NTHI | NeOnc Technologies Holdings, Inc. | 169.75M | 5.39% | 27,494 | 59.99K |
| 317 | CGEN | Compugen Ltd. | 168.36M | 7.78% | 333,409 | 22.14M |
| 318 | PALI | Palisade Bio, Inc. | 168.16M | -1.69% | 2,280,424 | - |
| 319 | ACTU | Actuate Therapeutics, Inc. | 165.04M | -0.69% | 68,495 | - |
| 320 | ELTX | Elicio Therapeutics, Inc. | 158.34M | 2.11% | 81,060 | - |
| 321 | NVCT | Nuvectis Pharma, Inc. | 157.32M | 2.83% | 197,270 | - |
| 322 | MCRB | Seres Therapeutics, Inc. | 156.27M | 0.68% | 65,930 | - |
| 323 | CYBN | Cybin Inc. | 155.47M | 2.83% | 470,993 | - |
| 324 | NAUT | Nautilus Biotechnology, Inc. | 154.09M | -15.86% | 801,093 | - |
| 325 | CGTX | Cognition Therapeutics, Inc. | 152.63M | 1.76% | 1,045,926 | - |
| 326 | ALEC | Alector, Inc. | 151.82M | 2.04% | 6,633,631 | 81.13M |
| 327 | VTVT | vTv Therapeutics Inc. | 149.75M | 0.29% | 1,812 | 17.00K |
| 328 | CRDF | Cardiff Oncology, Inc. | 148.35M | 0.90% | 787,319 | 545.00K |
| 329 | ACOG | Alpha Cognition Inc. | 144.43M | -1.14% | 24,592 | 4.59M |
| 330 | ACET | Adicet Bio, Inc. | 143.91M | 3.34% | 955,458 | - |
| 331 | TTRX | Turn Therapeutics Inc. | 142.36M | 2.63% | 290,469 | - |
| 332 | ANIX | Anixa Biosciences, Inc. | 136.28M | -0.96% | 138,075 | - |
| 333 | GLSI | Greenwich LifeSciences, Inc. | 136.17M | 8.71% | 85,304 | - |
| 334 | CLYM | Climb Bio, Inc. | 134.85M | - | 495,281 | - |
| 335 | ABOS | Acumen Pharmaceuticals, Inc. | 133.87M | 4.74% | 472,982 | - |
| 336 | ARTV | Artiva Biotherapeutics, Inc. | 132.14M | 11.78% | 996,532 | 251.00K |
| 337 | AGEN | Agenus Inc. | 131.92M | -0.96% | 401,285 | 101.71M |
| 338 | TCRX | TScan Therapeutics, Inc. | 131.09M | 0.87% | 326,808 | 6.96M |
| 339 | TVGN | Tevogen Bio Holdings Inc. | 131.06M | 4.76% | 224,153 | - |
| 340 | TIL | Instil Bio, Inc. | 130.96M | 2.11% | 39,990 | - |
| 341 | RANI | Rani Therapeutics Holdings, Inc. | 130.80M | -12.92% | 12,411,804 | 1.20M |
| 342 | MOLN | Molecular Partners AG | 129.32M | -0.56% | 1,420 | 856.30K |
| 343 | SEER | Seer, Inc. | 128.87M | 6.45% | 330,205 | 16.29M |
| 344 | IRD | Opus Genetics, Inc. | 125.46M | -0.50% | 242,792 | 15.42M |
| 345 | VTGN | Vistagen Therapeutics, Inc. | 124.87M | -2.16% | 401,235 | 646.00K |
| 346 | SPRO | Spero Therapeutics, Inc. | 124.37M | 0.45% | 451,642 | 48.58M |
| 347 | INO | Inovio Pharmaceuticals, Inc. | 123.82M | 3.56% | 628,013 | 182.34K |
| 348 | ZNTL | Zentalis Pharmaceuticals, Inc. | 123.35M | 4.27% | 484,472 | 26.87M |
| 349 | PRLD | Prelude Therapeutics Incorporated | 123.33M | 8.00% | 227,439 | 7.00M |
| 350 | STTK | Shattuck Labs, Inc. | 121.25M | 3.78% | 100,752 | 3.00M |
| 351 | ONCY | Oncolytics Biotech Inc. | 120.43M | 1.69% | 624,988 | - |
| 352 | ATOS | Atossa Therapeutics, Inc. | 120.41M | 1.84% | 636,946 | - |
| 353 | GNTA | Genenta Science S.p.A. | 118.71M | 91.95% | 21,921,465 | - |
| 354 | IMMX | Immix Biopharma, Inc. | 117.92M | 5.25% | 1,173,040 | - |
| 355 | SRZN | Surrozen, Inc. | 117.41M | -0.04% | 6,341 | 12.62M |
| 356 | MGNX | MacroGenics, Inc. | 116.30M | 0.55% | 406,136 | 165.50M |
| 357 | OVID | Ovid Therapeutics Inc. | 115.91M | 4.49% | 1,429,616 | 6.65M |
| 358 | IKT | Inhibikase Therapeutics, Inc. | 114.76M | 0.65% | 75,102 | 1.00 |
| 359 | HURA | TuHURA Biosciences, Inc. | 114.61M | 2.69% | 177,547 | - |
| 360 | WHWK | Whitehawk Therapeutics, Inc. | 113.58M | -1.63% | 562,179 | 21.60M |
| 361 | CNTX | Context Therapeutics Inc. | 113.03M | -1.56% | 110,842 | - |
| 362 | ANEB | Anebulo Pharmaceuticals, Inc. | 112.16M | 0.37% | 9,391 | - |
| 363 | PLRX | Pliant Therapeutics, Inc. | 111.11M | 3.43% | 1,141,179 | - |
| 364 | SLGL | Sol-Gel Technologies Ltd. | 108.65M | -2.26% | 18,016 | 23.93M |
| 365 | MGX | Metagenomi, Inc. | 108.47M | 3.96% | 273,242 | 33.77M |
| 366 | COYA | Coya Therapeutics, Inc. | 105.37M | -9.74% | 1,122,086 | 423.45K |
| 367 | BMEA | Biomea Fusion, Inc. | 103.23M | 5.80% | 1,667,497 | - |
| 368 | ATRA | Atara Biotherapeutics, Inc. | 101.77M | 2.62% | 39,362 | 188.67M |
| 369 | ENTX | Entera Bio Ltd. | 101.37M | 3.74% | 86,873 | 166.00K |
| 370 | EXOZ | eXoZymes, Inc. | 100.73M | 0.08% | 1,046 | -700.00 |
| 371 | ORMP | Oramed Pharmaceuticals Inc. | 98.00M | 0.84% | 136,413 | 2.00M |
| 372 | VANI | Vivani Medical, Inc. | 95.98M | -0.61% | 184,614 | - |
| 373 | PTHS | Pelthos Therapeutics Inc. | 95.92M | -9.00% | 9,147 | - |
| 374 | CSBR | Champions Oncology, Inc. | 95.00M | 2.07% | 16,384 | 56.88M |
| 375 | IFRX | InflaRx N.V. | 94.85M | 14.75% | 1,084,412 | 191.22K |
| 376 | CNTB | Connect Biopharma Holdings Limited | 94.73M | 4.94% | 31,878 | 1.97M |
| 377 | ATYR | aTyr Pharma, Inc. | 94.62M | -0.74% | 2,788,221 | 235.00K |
| 378 | QNCX | Quince Therapeutics, Inc. | 94.54M | -1.12% | 125,204 | - |
| 379 | ALXO | ALX Oncology Holdings Inc. | 93.71M | - | 443,577 | - |
| 380 | KLRS | Kalaris Therapeutics, Inc. | 90.71M | -0.82% | 42,286 | - |
| 381 | UNCY | Unicycive Therapeutics, Inc. | 90.60M | 5.56% | 419,138 | - |
| 382 | OKYO | OKYO Pharma Limited | 89.89M | 6.70% | 277,775 | - |
| 383 | IMA | ImageneBio, Inc. | 89.45M | 8.25% | 361,730 | 4.30M |
| 384 | STRO | Sutro Biopharma, Inc. | 89.01M | -0.94% | 672,629 | 104.47M |
| 385 | ESLA | Estrella Immunopharma, Inc. | 88.22M | 2.15% | 812,150 | - |
| 386 | NTRB | Nutriband Inc. | 85.91M | 2.14% | 58,993 | 2.58M |
| 387 | ADVM | Adverum Biotechnologies, Inc. | 85.41M | -2.63% | 13,615,172 | 1.00M |
| 388 | XFOR | X4 Pharmaceuticals, Inc. | 85.31M | 22.98% | 22,120,232 | 32.77M |
| 389 | ATHE | Alterity Therapeutics Limited | 84.93M | -1.30% | 14,881 | 3.57M |
| 390 | ADAG | Adagene Inc. | 84.37M | 0.01% | 8,855 | 103.20K |
| 391 | RPTX | Repare Therapeutics Inc. | 84.20M | 1.55% | 208,212 | 250.00K |
| 392 | CBUS | Cibus, Inc. | 84.07M | -1.90% | 104,297 | 4.85M |
| 393 | EQ | Equillium, Inc. | 83.90M | 6.02% | 176,772 | 16.55M |
| 394 | PMVP | PMV Pharmaceuticals, Inc. | 82.67M | -1.27% | 1,840,891 | - |
| 395 | VXRT | Vaxart, Inc. | 82.47M | -0.55% | - | 80.72M |
| 396 | BYSI | BeyondSpring Inc. | 81.07M | -0.50% | 18,946 | 1.88M |
| 397 | HOWL | Werewolf Therapeutics, Inc. | 80.94M | 12.74% | 1,064,846 | 1.14M |
| 398 | DTIL | Precision BioSciences, Inc. | 79.21M | -3.03% | 110,743 | 1.26M |
| 399 | XBIT | XBiotech Inc. | 78.96M | 5.28% | 70,897 | - |
| 400 | IMUX | Immunic, Inc. | 75.71M | -1.59% | 1,202,141 | - |
| 401 | HYFT | MindWalk Holdings Corp. | 75.69M | 6.49% | 505,560 | 18.21M |
| 402 | SPRB | Spruce Biosciences, Inc. | 75.08M | 2.56% | 132,999 | 1.30M |
| 403 | NRXP | NRx Pharmaceuticals, Inc. | 74.88M | -1.56% | 341,395 | - |
| 404 | FBIO | Fortress Biotech, Inc. | 74.68M | -0.40% | 365,160 | 59.30M |
| 405 | CVM | CEL-SCI Corporation | 73.22M | 1.89% | 40,361 | - |
| 406 | NSRX | Nasus Pharma Ltd. | 71.48M | 3.82% | 665 | - |
| 407 | COEP | Coeptis Therapeutics Holdings, Inc. | 71.24M | -6.75% | 56,984 | 263.56K |
| 408 | GANX | Gain Therapeutics, Inc. | 71.18M | 0.51% | 440,959 | - |
| 409 | RLMD | Relmada Therapeutics, Inc. | 69.70M | -4.98% | 103,260 | - |
| 410 | LITS | Lite Strategy, Inc. | 69.17M | 3.74% | 403,459 | - |
| 411 | ABVC | ABVC BioPharma, Inc. | 67.98M | 2.05% | 116,754 | 391.24K |
| 412 | INKT | MiNK Therapeutics, Inc. | 67.73M | 5.76% | 30,319 | - |
| 413 | JSPR | Jasper Therapeutics, Inc. | 66.18M | 1.72% | 775,673 | - |
| 414 | IOBT | IO Biotech, Inc. | 65.88M | - | 1,482,281 | - |
| 415 | CRVO | CervoMed Inc. | 65.42M | -0.14% | 43,895 | 7.78M |
| 416 | ACRV | Acrivon Therapeutics, Inc. | 65.11M | 3.50% | 306,129 | - |
| 417 | RVPH | Reviva Pharmaceuticals Holdings, Inc. | 65.06M | 19.00% | 32,010,457 | - |
| 418 | OSTX | OS Therapies Incorporated | 63.38M | 4.42% | 294,284 | - |
| 419 | OTLK | Outlook Therapeutics, Inc. | 61.74M | 6.92% | 1,205,894 | 1.51M |
| 420 | PSTV | Plus Therapeutics, Inc. | 61.08M | -3.07% | 7,495,950 | 5.32M |
| 421 | ANL | Adlai Nortye Ltd. | 60.96M | -0.49% | 2,524 | 1.94M |
| 422 | CUE | Cue Biopharma, Inc. | 60.34M | 0.63% | 91,897 | 8.29M |
| 423 | MNOV | MediciNova, Inc. | 60.33M | 0.41% | 66,425 | 134.60K |
| 424 | ALGS | Aligos Therapeutics, Inc. | 59.58M | 2.05% | 52,978 | 3.17M |
| 425 | CELU | Celularity Inc. | 55.79M | 5.03% | 72,586 | 44.59M |
| 426 | VERU | Veru Inc. | 55.67M | 2.15% | 110,117 | 16.89M |
| 427 | SER | Serina Therapeutics, Inc. | 55.43M | 1.74% | 36,295 | 130.00K |
| 428 | ICCC | ImmuCell Corporation | 55.00M | 0.33% | 11,053 | 28.27M |
| 429 | KPTI | Karyopharm Therapeutics Inc. | 54.98M | 2.42% | 84,549 | 137.27M |
| 430 | SNTI | Senti Biosciences, Inc. | 54.41M | 4.00% | 117,519 | - |
| 431 | BRNS | Barinthus Biotherapeutics plc | 54.30M | 3.10% | 58,359 | 14.97M |
| 432 | HYPD | Hyperion DeFi, Inc. | 53.86M | -4.21% | 518,855 | 44.44K |
| 433 | PYPD | PolyPid Ltd. | 53.85M | - | 25,015 | - |
| 434 | JUNS | Jupiter Neurosciences, Inc. | 53.29M | 3.38% | 195,127 | - |
| 435 | QNTM | Quantum BioPharma Ltd. | 53.05M | -3.74% | 83,603 | - |
| 436 | ATNM | Actinium Pharmaceuticals, Inc. | 52.10M | 16.78% | 1,888,002 | 81.00K |
| 437 | TELO | Telomir Pharmaceuticals, Inc. | 50.75M | 1.35% | 1,251,230 | - |
| 438 | INMB | INmune Bio, Inc. | 50.51M | 6.15% | 345,469 | 50.00K |
| 439 | IPSC | Century Therapeutics, Inc. | 49.87M | -2.15% | 888,175 | 114.13M |
| 440 | APLM | Apollomics, Inc. | 49.36M | -18.47% | 13,833 | 198.00K |
| 441 | MRSN | Mersana Therapeutics, Inc. | 48.81M | -0.41% | 30,439 | 34.77M |
| 442 | ANVS | Annovis Bio, Inc. | 47.77M | 1.49% | 267,762 | - |
| 443 | SKYE | Skye Bioscience, Inc. | 47.72M | 6.21% | 625,312 | - |
| 444 | TPST | Tempest Therapeutics, Inc. | 47.42M | 3.39% | 26,708 | - |
| 445 | MAIA | MAIA Biotechnology, Inc. | 47.18M | -2.05% | 527,188 | - |
| 446 | TVRD | Tvardi Therapeutics, Inc. | 46.61M | -3.68% | 260,082 | - |
| 447 | BTAI | BioXcel Therapeutics, Inc. | 45.78M | 3.10% | 784,028 | 868.00K |
| 448 | KZR | Kezar Life Sciences, Inc. | 45.11M | 0.16% | 95,763 | - |
| 449 | OKUR | OnKure Therapeutics, Inc. | 44.92M | 11.41% | 634,600 | - |
| 450 | BCAB | BioAtla, Inc. | 44.63M | 5.86% | 1,706,313 | 11.00M |
| 451 | LTRN | Lantern Pharma Inc. | 44.06M | 10.27% | 123,962 | - |
| 452 | FGEN | FibroGen, Inc. | 43.80M | 1.12% | 14,346 | 7.35M |
| 453 | GRCE | Grace Therapeutics, Inc. | 43.46M | -0.22% | 47,196 | - |
| 454 | PDSB | PDS Biotechnology Corporation | 43.24M | -0.02% | 297,036 | - |
| 455 | RNXT | RenovoRx, Inc. | 43.24M | 2.61% | 155,237 | 662.00K |
| 456 | LVTX | LAVA Therapeutics N.V. | 42.35M | - | 149,273 | 4.99M |
| 457 | DYAI | Dyadic International, Inc. | 42.34M | -0.85% | 127,653 | 4.14M |
| 458 | CALC | CalciMedica, Inc. | 42.34M | -1.30% | 34,611 | - |
| 459 | GBIO | Generation Bio Co. | 41.09M | -1.13% | 32,105 | 21.23M |
| 460 | XLO | Xilio Therapeutics, Inc. | 40.94M | 2.19% | 402,131 | 15.00M |
| 461 | RADX | Radiopharm Theranostics Limited | 40.02M | -4.14% | 22,355 | 8.20M |
| 462 | KLTO | Klotho Neurosciences, Inc. | 39.57M | 4.48% | 777,081 | - |
| 463 | IGC | IGC Pharma, Inc. | 37.41M | 7.90% | 2,379,029 | 1.33M |
| 464 | EVAX | Evaxion A/S | 37.20M | 4.99% | 263,868 | 3.18M |
| 465 | VRCA | Verrica Pharmaceuticals Inc. | 36.37M | -2.53% | 80,507 | 14.70M |
| 466 | QTTB | Q32 Bio Inc. | 36.23M | 6.07% | 98,579 | - |
| 467 | MURA | Mural Oncology plc | 36.21M | - | 215,758 | - |
| 468 | NRXS | NeurAxis, Inc. | 34.46M | -8.64% | 18,560,350 | 3.22M |
| 469 | SONN | Sonnet BioTherapeutics Holdings, Inc. | 33.73M | 11.26% | 736,901 | 1.00M |
| 470 | LIMN | Liminatus Pharma, Inc. | 33.56M | 3.33% | 348,984 | - |
| 471 | RNTX | Rein Therapeutics Inc. | 33.56M | 14.29% | 115,155 | - |
| 472 | NERV | Minerva Neurosciences, Inc. | 32.87M | -3.49% | 881,566 | - |
| 473 | BOLD | Boundless Bio, Inc. | 32.68M | 3.55% | 126,831 | - |
| 474 | ANTX | AN2 Therapeutics, Inc. | 32.46M | 1.54% | 106,312 | - |
| 475 | PLUR | Pluri Inc. | 31.81M | 0.52% | 7,611 | 1.34M |
| 476 | XCUR | Exicure, Inc. | 31.59M | 5.49% | 26,422 | 500.00K |
| 477 | SABS | SAB Biotherapeutics, Inc. | 31.55M | 3.77% | 201,130 | 114.70K |
| 478 | ITRM | Iterum Therapeutics plc | 31.02M | 0.61% | 569,692 | - |
| 479 | CTXR | Citius Pharmaceuticals, Inc. | 30.96M | 5.81% | 878,948 | - |
| 480 | NRSN | NeuroSense Therapeutics Ltd. | 29.55M | 1.72% | 193,072 | - |
| 481 | CLGN | CollPlant Biotechnologies Ltd. | 28.99M | 0.22% | 37,594 | 2.40M |
| 482 | CVKD | Cadrenal Therapeutics, Inc. | 28.93M | 2.65% | 24,614 | - |
| 483 | DARE | Daré Bioscience, Inc. | 27.81M | 0.96% | 81,745 | -17.70K |
| 484 | GDTC | CytoMed Therapeutics Limited | 27.58M | -1.65% | 34,149 | 573.19K |
| 485 | LPTX | Leap Therapeutics, Inc. | 27.11M | 2.33% | 476,472 | - |
| 486 | NNVC | NanoViricides, Inc. | 26.67M | 6.84% | 255,341 | - |
| 487 | ENLV | Enlivex Therapeutics Ltd. | 25.87M | 0.95% | 125,024 | - |
| 488 | BCTX | BriaCell Therapeutics Corp. | 25.75M | 4.95% | 82,288 | - |
| 489 | RLYB | Rallybio Corporation | 25.49M | 1.67% | 194,789 | 761.00K |
| 490 | CASI | CASI Pharmaceuticals, Inc. | 25.41M | 1.86% | 11,892 | 31.56M |
| 491 | LNAI | Lunai Bioworks Inc. | 25.03M | 3.85% | 182,533 | - |
| 492 | NXTC | NextCure, Inc. | 24.62M | 3.49% | 35,321 | - |
| 493 | IBIO | iBio, Inc. | 24.51M | -4.72% | 4,253,831 | 400.00K |
| 494 | AKTX | Akari Therapeutics, Plc | 24.13M | 0.14% | 82,280 | - |
| 495 | MBRX | Moleculin Biotech, Inc. | 24.06M | -0.90% | 1,951,673 | - |
| 496 | MTVA | MetaVia Inc. | 23.71M | 1.97% | 22,102 | - |
| 497 | PMN | ProMIS Neurosciences, Inc. | 23.22M | 0.58% | 338,538 | - |
| 498 | PASG | Passage Bio, Inc. | 22.71M | -3.86% | 44,217 | - |
| 499 | KAPA | Kairos Pharma, Ltd. | 22.61M | - | 129,295 | - |
| 500 | CING | Cingulate Inc. | 21.64M | 7.82% | 372,427 | - |
| 501 | SYBX | Synlogic, Inc. | 20.71M | 2.91% | 10,770 | 8.00K |
| 502 | LEXX | Lexaria Bioscience Corp. | 20.65M | 2.04% | 118,226 | 615.92K |
| 503 | LSTA | Lisata Therapeutics, Inc. | 20.58M | - | 9,067 | 1.07M |
| 504 | CLSD | Clearside Biomedical, Inc. | 20.41M | 2.63% | 33,744 | 4.17M |
| 505 | ALLR | Allarity Therapeutics, Inc. | 20.19M | - | 275,470 | - |
| 506 | CRIS | Curis, Inc. | 20.12M | -1.23% | 121,663 | 11.41M |
| 507 | LIXT | Lixte Biotechnology Holdings, Inc. | 19.71M | -0.23% | 44,090 | - |
| 508 | PPCB | Propanc Biopharma, Inc. | 19.47M | 2.70% | 70,147 | - |
| 509 | LGVN | Longeveron Inc. | 19.38M | 8.24% | 959,917 | 2.07M |
| 510 | TRAW | Traws Pharma, Inc. | 19.31M | 3.04% | 147,219 | 2.90M |
| 511 | EDSA | Edesa Biotech, Inc. | 19.28M | 1.86% | 12,373 | - |
| 512 | FBLG | FibroBiologics, Inc. | 18.28M | 6.28% | 1,284,058 | - |
| 513 | THAR | Tharimmune, Inc. | 18.24M | 6.55% | 303,301 | - |
| 514 | HOTH | Hoth Therapeutics, Inc. | 18.16M | 0.74% | 328,375 | - |
| 515 | PULM | Pulmatrix, Inc. | 17.46M | -1.44% | 3,208 | 3.00K |
| 516 | ADAP | Adaptimmune Therapeutics plc | 17.15M | -7.57% | 47,848,434 | 65.09M |
| 517 | ICU | SeaStar Medical Holding Corporation | 17.13M | -2.65% | 971,451 | 766.00K |
| 518 | ASBP | Aspire Biopharma Holdings, Inc. | 17.05M | 2.47% | 1,716,230 | - |
| 519 | GOVX | GeoVax Labs, Inc. | 16.83M | 4.89% | 683,974 | 6.14M |
| 520 | CMMB | Chemomab Therapeutics Ltd. | 16.81M | 11.68% | 112,338 | - |
| 521 | BLRX | BioLineRx Ltd. | 16.67M | 1.64% | 15,940 | 17.25M |
| 522 | ATHA | Athira Pharma, Inc. | 16.05M | 2.01% | 6,745 | - |
| 523 | ABP | Abpro Holdings, Inc. | 16.03M | -0.05% | 2,242,567 | 183.00K |
| 524 | LPCN | Lipocine Inc. | 15.72M | 3.94% | 36,504 | 4.21M |
| 525 | IMRN | Immuron Limited | 15.71M | -0.46% | 31,085 | 4.78M |
| 526 | PCSA | Processa Pharmaceuticals, Inc. | 15.62M | 1.21% | 4,645,811 | - |
| 527 | CANF | Can-Fite BioPharma Ltd. | 15.57M | -4.43% | 259,202 | 560.00K |
| 528 | PHGE | BiomX Inc. | 15.40M | 0.92% | 337,524 | - |
| 529 | COCP | Cocrystal Pharma, Inc. | 15.39M | 11.32% | 471,242 | - |
| 530 | BCDA | BioCardia, Inc. | 14.75M | -0.36% | 104,196 | 3.00K |
| 531 | NEUP | Neuphoria Therapeutics Inc. | 14.71M | 54.07% | 83,665,690 | 15.65M |
| 532 | BIVI | BioVie Inc. | 14.17M | -0.53% | 59,659 | - |
| 533 | BRTX | BioRestorative Therapies, Inc. | 13.59M | -0.32% | 15,152 | 605.20K |
| 534 | DWTX | Dogwood Therapeutics, Inc. | 13.48M | 4.63% | 133,593 | - |
| 535 | MRKR | Marker Therapeutics, Inc. | 13.33M | 3.56% | 204,066 | 5.39M |
| 536 | SNSE | Sensei Biotherapeutics, Inc. | 13.32M | 0.96% | 3,981 | - |
| 537 | SNGX | Soligenix, Inc. | 13.19M | -1.25% | 635,476 | 2.34K |
| 538 | OSRH | OSR Holdings, Inc. | 13.03M | -6.55% | 870,317 | 104.74K |
| 539 | CLRB | Cellectar Biosciences, Inc. | 12.77M | 5.82% | 74,627 | - |
| 540 | PLRZ | Polyrizon Ltd. | 12.67M | -0.93% | 282,735 | - |
| 541 | CELZ | Creative Medical Technology Holdings, Inc. | 12.59M | 18.16% | 243,766 | 6.00K |
| 542 | IMNN | Imunon, Inc. | 12.23M | -1.22% | 52,369 | - |
| 543 | PHIO | Phio Pharmaceuticals Corp. | 12.20M | -0.47% | 27,969 | - |
| 544 | INTS | Intensity Therapeutics, Inc. | 11.67M | -1.25% | 2,091,888 | - |
| 545 | XTLB | XTL Biopharmaceuticals Ltd. | 11.52M | -0.81% | 49,164 | 451.00K |
| 546 | BOLT | Bolt Biotherapeutics, Inc. | 11.52M | 4.17% | 10,158 | 4.17M |
| 547 | GLTO | Galecto, Inc. | 11.17M | 1.69% | 174,775 | - |
| 548 | RNAZ | TransCode Therapeutics, Inc. | 11.16M | 1.90% | 8,812 | - |
| 549 | EVGN | Evogene Ltd. | 10.97M | 0.81% | 69,053 | 9.44M |
| 550 | AEON | AEON Biopharma, Inc. | 10.95M | 3.43% | 182,081 | - |
| 551 | MBIO | Mustang Bio, Inc. | 10.79M | 3.47% | 63,774 | - |
| 552 | APM | Aptorum Group Limited | 10.64M | -0.67% | 133,110 | - |
| 553 | LYRA | Lyra Therapeutics, Inc. | 10.47M | 1.43% | 17,460 | 770.00K |
| 554 | ACXP | Acurx Pharmaceuticals, Inc. | 9.94M | 0.15% | 80,371 | - |
| 555 | INAB | IN8bio, Inc. | 9.71M | 1.90% | 14,718 | - |
| 556 | ERNA | Ernexa Therapeutics Inc. | 9.51M | 5.98% | 16,663 | 488.00K |
| 557 | VYNE | VYNE Therapeutics Inc. | 9.51M | 0.92% | 856,265 | 476.00K |
| 558 | ALZN | Alzamend Neuro, Inc. | 9.47M | 6.87% | 199,130 | - |
| 559 | XBIO | Xenetic Biosciences, Inc. | 9.13M | 3.89% | 80,162 | 2.45M |
| 560 | MTNB | Matinas BioPharma Holdings, Inc. | 8.89M | 1.27% | 6,615 | - |
| 561 | KPRX | Kiora Pharmaceuticals, Inc. | 8.79M | 0.79% | 52,674 | 20.00K |
| 562 | ADXN | Addex Therapeutics Ltd | 8.67M | -2.54% | 8,933 | 210.35K |
| 563 | HCWB | HCW Biologics Inc. | 8.43M | 0.51% | 14,975 | 832.84K |
| 564 | ARTL | Artelo Biosciences, Inc. | 8.32M | -0.88% | 20,110 | - |
| 565 | GNPX | Genprex, Inc. | 8.25M | 4.91% | 452,797 | - |
| 566 | APRE | Aprea Therapeutics, Inc. | 8.16M | -7.89% | 432,765 | 841.01K |
| 567 | NCNA | NuCana plc | 8.13M | 1.67% | 90,229 | - |
| 568 | SILO | Silo Pharma, Inc. | 7.92M | 6.58% | 1,053,806 | 72.10K |
| 569 | ADIL | Adial Pharmaceuticals, Inc. | 7.91M | 1.03% | 512,969 | - |
| 570 | KZIA | Kazia Therapeutics Limited | 7.80M | 4.60% | 21,049 | 1.55M |
| 571 | JAGX | Jaguar Health, Inc. | 7.78M | 5.53% | 23,203 | 11.81M |
| 572 | QNRX | Quoin Pharmaceuticals, Ltd. | 7.62M | -3.36% | 56,867 | - |
| 573 | GLMD | Galmed Pharmaceuticals Ltd. | 7.56M | 1.10% | 31,239 | - |
| 574 | NBY | NovaBay Pharmaceuticals, Inc. | 7.39M | - | 167,909 | 9.78M |
| 575 | IBO | Impact BioMedical Inc. | 7.16M | 0.65% | 39,003 | 7.00K |
| 576 | CDIO | Cardio Diagnostics Holdings, Inc. | 7.14M | 2.27% | 17,010 | 19.51K |
| 577 | CYCN | Cyclerion Therapeutics, Inc. | 6.79M | -0.47% | 21,985 | 2.17M |
| 578 | PMCB | PharmaCyte Biotech, Inc. | 6.64M | 1.78% | 35,698 | - |
| 579 | ENSC | Ensysce Biosciences, Inc. | 6.62M | 5.69% | 56,215 | 7.41M |
| 580 | SPRC | SciSparc Ltd. | 6.52M | 1.01% | 97,842 | 1.31M |
| 581 | ENTO | Entero Therapeutics, Inc. | 6.42M | -7.34% | 143,933 | - |
| 582 | TCRT | Alaunos Therapeutics, Inc. | 6.22M | 4.06% | 49,754 | 6.00K |
| 583 | CLDI | Calidi Biotherapeutics, Inc. | 6.20M | 1.32% | 71,922 | - |
| 584 | QLGN | Qualigen Therapeutics, Inc. | 6.17M | 3.12% | 51,508,148 | - |
| 585 | VIVS | VivoSim Labs, Inc. | 6.06M | 5.91% | 837,303 | 142.00K |
| 586 | PPBT | Purple Biotech Ltd | 6.04M | 2.20% | 230,003 | - |
| 587 | SXTP | 60 Degrees Pharmaceuticals, Inc. | 6.03M | 1.38% | 166,483 | 984.49K |
| 588 | PTIX | Protagenic Therapeutics, Inc. | 5.86M | 2.34% | 32,784 | - |
| 589 | KALA | KALA BIO, Inc. | 5.59M | 1.75% | 394,355 | - |
| 590 | CMND | Clearmind Medicine Inc. | 5.52M | 2.82% | 52,644 | - |
| 591 | ONCO | Onconetix, Inc. | 5.47M | 5.33% | 15,009 | 1.33M |
| 592 | OGEN | Oragenics, Inc. | 5.45M | 3.13% | 37,817 | - |
| 593 | NLSP | NLS Pharmaceutics AG | 5.40M | -1.52% | 319,162 | - |
| 594 | KTTA | Pasithea Therapeutics Corp. | 5.35M | -1.60% | 15,677 | - |
| 595 | GRI | GRI Bio, Inc. | 5.16M | 0.99% | 83,598 | - |
| 596 | APVO | Aptevo Therapeutics Inc. | 5.00M | -0.65% | 706,408 | - |
| 597 | CNSP | CNS Pharmaceuticals, Inc. | 4.74M | 2.52% | 9,101 | - |
| 598 | ELAB | PMGC Holdings Inc. | 4.49M | -1.15% | 71,309 | -605.53K |
| 599 | BDRX | Biodexa Pharmaceuticals Plc | 4.45M | 5.74% | 13,985 | 104.90K |
| 600 | INDP | Indaptus Therapeutics, Inc. | 4.02M | 2.25% | 36,443 | - |
| 601 | ENVB | Enveric Biosciences, Inc. | 3.91M | 2.56% | 509,362 | - |
| 602 | XRTX | XORTX Therapeutics Inc. | 3.38M | -8.09% | 441,346 | - |
| 603 | TOVX | Theriva Biologics, Inc. | 3.31M | 0.88% | 549,584,258 | - |
| 604 | REVB | Revelation Biosciences, Inc. | 2.97M | 4.96% | 148,590 | - |
| 605 | DRMA | Dermata Therapeutics, Inc. | 2.73M | -4.02% | 84,625 | - |
| 606 | MLEC | Moolec Science SA | 2.73M | 0.21% | 43,179 | 7.83M |
| 607 | VRAX | Virax Biolabs Group Limited | 2.54M | -0.83% | 89,318 | 6.33K |
| 608 | GTBP | GT Biopharma, Inc. | 2.44M | -6.36% | 743,476 | - |
| 609 | CERO | CERo Therapeutics Holdings, Inc. | 2.30M | -4.50% | 593,086 | - |
| 610 | SCNI | Scinai Immunotherapeutics Ltd. | 2.21M | 2.82% | 57,363 | 1.15M |
| 611 | AZTR | Azitra, Inc. | 2.01M | 4.68% | 660,981 | 7.50K |
| 612 | SLRX | Salarius Pharmaceuticals, Inc. | 2.01M | 4.79% | 57,171 | - |
| 613 | PBM | Psyence Biomedical Ltd. | 1.95M | 0.15% | 26,666 | - |
| 614 | SLXN | Silexion Therapeutics Corp | 1.93M | 2.08% | 35,670 | - |
| 615 | CDT | CDT Equity Inc. | 1.15M | -2.90% | 80,000 | - |
| 616 | ADTX | Aditxt, Inc. | 1.07M | -28.06% | 82,958,861 | 12.05K |